← Every applicant
Qilu FDA Approvals
11 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| CYCLOSPORINENew drugSep 15, 2025CAPSULE, ORAL |
| MIRABEGRONNew drugJun 30, 2025TABLET, EXTENDED RELEASE, ORAL |
| OLANZAPINENew drugMay 16, 2025POWDER, INTRAMUSCULAR |
| GANIRELIX ACETATENew drugApr 23, 2025INJECTABLE, INJECTION |
| ICOSAPENT ETHYLNew drugNov 20, 2024CAPSULE, ORAL |
| MEROPENEMNew drugJul 22, 2024INJECTABLE, INJECTION |
| CISPLATINNew drugMay 10, 2024INJECTABLE, INJECTION |
| CETRORELIX ACETATENew drugApr 16, 2024POWDER, SUBCUTANEOUS |
| AMIKACIN SULFATENew drugMar 19, 2024INJECTABLE, INJECTION |
| HYDROXYUREANew drugMar 6, 2024CAPSULE, ORAL |
| LENALIDOMIDENew drugFeb 22, 2024CAPSULE, ORAL |